Fresenius SE Reports Higher Profit, Revenue and Plans Dividend

Fresenius SE demonstrates strong growth with increased profit and revenue. The company aims to pay a dividend of 1.00 euros per share for fiscal 2024, showing confidence in future performance.

Date: 26-02-2025

AI Rating: 7

Profit Margins and Earnings Per Share
Fresenius SE reported an impressive 27% increase in net income for the quarter, rising from 306 million euros to 390 million euros. The earnings per share (EPS), excluding Fresenius Medical Care (FMC), also improved significantly from 0.55 euros to 0.69 euros year-on-year. This improvement in EPS signals strong profitability.

Revenue Growth
The report indicates that Group revenue has increased by 7%, from 5.18 billion euros to 5.53 billion euros. The organic revenue growth matches the overall revenue growth at a remarkable 7%. This robust revenue performance is attributed to the solid contributions from Fresenius Kabi and Fresenius Helios.

Future Projections
Fresenius SE has set ambitious yet achievable targets for the upcoming fiscal years. For FY 2025, the company anticipates organic revenue growth between 4% to 6%, alongside a constant currency EBIT growth between 3% to 7%. Furthermore, the EBIT margin for Fresenius Kabi is projected to remain robust between 16.0% to 16.5%.

Overall, these metrics and projections suggest that Fresenius SE is on a positive trajectory, which could have a favorable impact on its stock prices moving forward.

Stocks: FSNUF FSNPF